6990 — Sichuan Kelun-Biotech Biopharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$108.71bn
- HK$103.19bn
- CNY2.06bn
Brief: Sichuan Kelun-Biotech Biopharmaceutical Receives NMPA Approval For IND Application For SKB118 (CR-001)
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Accepts New Indication Application For Sacituzumab Tirumotecan
Brief: Sichuan Kelun-Biotech Biopharmaceutical Subscribes To CZB Structured Deposit II For RMB100 MLN On Apr 15
Brief: Sichuan Kelun-Biotech Biopharmaceutical Posts FY Loss Attributable RMB 382 Million
Sichuan Kelun-Biotech jumps most in near 12 months on drug application
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves IND Application For SKB575/HBM7575
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says Trop2 Adc Sacituzumab Tirumotecan Approved For Marketing For Fourth Indication By China's NMPA
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says Subscription For BOC Structured Deposit II Terminated
Brief: Sichuan Kelun-Biotech Biopharmaceutical Subscribes For Wealth Management Products
Brief: Sichuan Kelun-Biotech Biopharmaceutical SAC-TMT In Combination With Immunotherapy Pembrolizumab Granted Breakthrough Therapy Designation By NMPA
Brief: Sichuan Kelun-Biotech Biopharmaceutical Enters Settlement Agreement With Medilink Therapeutics (Suzhou), Others
China's Kelun-Biotech licenses cancer treatment to Crescent Biopharma
Brief: Sichuan Kelun-Biotech Biopharmaceutical Partners With Crescent Biopharma
Brief: Kelun-Biotech And Crescent Biopharma Announce Strategic Partnership
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves Trastuzumab Botidotin For Marketing
Brief: Sichuan Kelun-Biotech Biopharmaceutical To Subscribe For BOC Structured Deposit At Principal Amount Of RMB440 Million
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says Drug Application For A400/EP0031 Accepted For Review
Brief: Sichuan Kelun-Biotech Biopharmaceutical Subscribes RMB200 MLN Deposit With Industrial Bank
Sichuan Kelun-Biotech falls most in 4 weeks on discounted share sale